查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563085

虾疾病诊断市场：全球产业分析、规模、占有率、成长、趋势、2024-2033年预测

Shrimp Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 215 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球虾疾病诊断市场的综合报告，深入分析了关键市场动态，包括市场驱动因素、趋势、机会和挑战。这份详细的报告揭示了预测期内的市场结构和成长潜力。

主要见解

  • 虾疾病诊断市场规模（2024年）：5.009亿美元
  • 预估市场规模（2033年）：8.21亿美元
  • 全球市场成长率（2024-2033年年复合成长率）：5.6%

虾疾病诊断市场-调查范围

虾疾病诊断市场致力于影响虾子的各种疾病诊断测试的开发和应用，这对水产养殖非常重要。这个市场包括各种诊断方法，例如分子诊断、免疫诊断和生化测试。主要成长动力包括全球对虾需求的增加、水产养殖活动的增加以及可持续虾养殖的需求。

市场驱动因素：

有几个关键因素推动全球虾疾病诊断市场的成长。在消费和出口增加的推动下，全球对虾的需求不断增加是一个主要因素。此外，维持虾群健康以确保水产养殖的生产力和盈利能力的需求推动诊断解决方案的采用。虾农疾病控制和预防意识的提高也支持了市场的成长。

市场限制因素：

儘管存在成长潜力，但虾疾病诊断市场仍面临一些挑战。先进诊断技术的高成本可能会限制其采用，特别是在小规模农民中。此外，缺乏标准化测试协议和对可用诊断解决方案的认识不足可能会阻碍市场扩张。监管挑战和虾疾病流行的区域差异也可能是主要障碍。

市场机会：

虾疾病诊断市场提供了巨大的成长机会，特别是由于技术的进步。分子诊断的创新，例如基于 PCR 的检测，预计将提高检测疾病的能力。诊断公司和水产养殖利益相关者之间的合作可以促进创新并扩大市场范围。此外，增加研发投资以开发具有成本效益且易于使用的诊断工具进一步扩大了成长机会。

本报告涵盖的主要问题

  • 推动全球虾疾病诊断市场的关键因素是什么？
  • 哪些地区采用虾疾病诊断最多？
  • 诊断技术的进步如何影响竞争格局？
  • 谁是虾疾病诊断市场的主要参与者？ 他们采取了哪些策略来维持其市场地位？
  • 全球虾疾病诊断市场的新趋势和未来前景是什么？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含和排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 市场创新/发展趋势

第4章 关键成功因素

  • 产品采用率分析
  • 最近的产品核准
  • 监理状况
  • 兑换场景
  • 供应链分析
  • 波特的分析
  • PESTLE分析

第5章 市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第6章 COVID-19 危机分析

  • 新冠肺炎（COVID-19）与影响分析
    • 试剂盒
    • 依疾病分类
    • 依最终用户
    • 依国家/地区
  • 2024年市场情景

第7章 全球市场需求（金额或规模，百万美元）分析

  • 2019-2023年过去的市值（百万美元）分析
  • 依市场分类的2024-2033年当前和未来市场规模分析和预测（百万美元）
    • 年成长趋势分析
    • 绝对的获利机会

第8章 依试剂盒的世界市场分析

  • 简介/主要调查结果
  • 2019-2023年依试剂盒的市场规模（百万美元）实绩分析
  • 2024-2033年依试剂盒的当前和未来市场规模（百万美元）分析和预测
    • 快速检测试剂盒
    • 基于检测的试剂盒
  • 试剂盒市场吸引力分析

第9章 依疾病的世界市场分析

  • 简介/主要调查结果
  • 2019-2023年依疾病的市场规模（百万美元）实绩分析
  • 2024-2033年依疾病的当前和未来市场规模（百万美元）分析和预测
    • WSSV（白斑症病毒）
    • TSV（Taura症候群病毒）
    • YHV/GAV（黄头/鳃相关病毒）
    • IHHNV（传染性皮下组织与造血病毒）
    • HPV（对虾肝胰腺细小病毒）
    • MBV（草虾桿状病毒）
    • IMNV（传染性肌肉坏死病毒）
    • NHP-B（坏死性肝胰臟炎菌）
    • MoV（Mourilyan 病毒）
    • 早期死亡症候群（EMS）
  • 依疾病分析市场吸引力

第10章 依最终用户的全球市场分析

  • 简介/主要调查结果
  • 2019-2023年市场规模（百万美元）的过去分析，依最终用户
  • 2024-2033年当前和未来市场规模（百万美元）的分析和预测，依最终用户
    • 渔业
    • 水产养殖研究所
    • 海洋研究所
    • 教育与研究机构
    • 其他
  • 依最终用户的市场吸引力分析

第11章 依地区的世界市场分析

  • 简介/主要调查结果
  • 2019-2023年过去市场规模（百万美元）分析，依地区
  • 2024-2033年当前和未来市场规模（百万美元）分析和预测，依地区
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东、非洲
  • 依地区市场吸引力分析

第12章 北美市场分析

第13章 拉丁美洲市场分析

第14章 欧洲市场分析

第15章 东亚市场分析

第16章 南亚市场分析

第17章 大洋洲市场

第18章 中东、非洲市场分析

第19章 市场结构分析

  • 依公司层级的市场分析
  • 主要公司市场占有率分析
  • 市场现况分析

第20章 竞争分析

  • 竞争仪表板
  • 品牌与推广策略
  • 主要发展分析
  • 竞争详情
    • HiMedia Laboratories
    • HiMedia Laboratories
    • Speedy Assay Sdn Bhd
    • REAGEN LLC
    • FUJIKURA KASEI CO., LTD.
    • GeneReach Biotechnology Corp.
    • Thermo Fisher Scientific
    • Lab-Ind Resource Sdn Bhd.
    • SUREBIO
    • Auro Biotechnologies Pvt. Ltd.

第21章 使用的假设与缩写

第22章 研究方法

简介目录
Product Code: PMRREP29626

Persistence Market Research has recently released a comprehensive report on the global Shrimp Disease Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

  • Shrimp Disease Diagnostics Market Size (2024E): US$500.9 million
  • Projected Market Value (2033F): US$821 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.6%

Shrimp Disease Diagnostics Market - Report Scope:

The Shrimp Disease Diagnostics Market focuses on the development and application of diagnostic tests for various diseases affecting shrimp, which are vital to aquaculture. The market encompasses various diagnostic methods, including molecular diagnostics, immunodiagnostics, and biochemical tests. Key growth drivers include the rising global demand for shrimp, increasing aquaculture activities, and the need for sustainable shrimp farming practices.

Market Growth Drivers:

Several key factors are driving the growth of the global Shrimp Disease Diagnostics Market. The increasing global demand for shrimp, fueled by rising consumption and exports, is a significant contributor. Furthermore, the need to maintain healthy shrimp populations to ensure productivity and profitability in aquaculture is pushing the adoption of diagnostic solutions. Increased awareness of disease management and prevention among shrimp farmers also supports market growth.

Market Restraints:

Despite its growth potential, the Shrimp Disease Diagnostics Market faces several challenges. High costs associated with advanced diagnostic technologies can limit their adoption, especially among small-scale farmers. Additionally, a lack of standardized testing protocols and limited awareness of available diagnostic solutions can hinder market expansion. Regulatory challenges and the varying prevalence of shrimp diseases across regions may also pose significant barriers.

Market Opportunities:

The Shrimp Disease Diagnostics Market presents substantial growth opportunities, particularly through advancements in technology. Innovations in molecular diagnostics, such as PCR-based tests, are expected to enhance disease detection capabilities. Collaborations between diagnostic companies and aquaculture stakeholders can drive innovation and expand market reach. Furthermore, increasing investment in research and development to create cost-effective and user-friendly diagnostic tools presents further opportunities for growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the global Shrimp Disease Diagnostics Market?
  • Which regions are witnessing the highest adoption of shrimp disease diagnostics, and what trends are influencing this growth?
  • How are advancements in diagnostic technologies impacting the competitive landscape?
  • Who are the leading players in the Shrimp Disease Diagnostics Market, and what strategies are they implementing to maintain their market positions?
  • What are the emerging trends and future prospects in the global Shrimp Disease Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the Shrimp Disease Diagnostics Market, including companies like IDEXX Laboratories, Neogen Corporation, and Thermo Fisher Scientific, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic solutions and enhancing their distribution networks. Collaborations with aquaculture stakeholders, research institutions, and regulatory bodies are crucial for market penetration and sustained growth. Ensuring compliance with global regulatory standards and addressing the unique needs of shrimp farmers will help these companies maintain a competitive edge and achieve long-term success in the Shrimp Disease Diagnostics Market.

Key Companies Profiled:

  • HiMedia Laboratories
  • HiMedia Laboratories
  • Speedy Assay Sdn Bhd
  • REAGEN LLC
  • FUJIKURA KASEI CO., LTD.
  • GeneReach Biotechnology Corp.
  • Thermo Fisher Scientific
  • Lab - Ind Resource Sdn Bhd.
  • SUREBIO
  • Auro Biotechnologies Pvt. Ltd.

Key Segments Covered in Shrimp disease diagnostics Industry Research

Reagent:

  • Rapid Testing Kits
  • Assay Based Kits

Disease:

  • WSSV (White Spot Syndrome Virus)
  • TSV (Taura Syndrome Virus)
  • YHV/GAV (Yellow Head/Gill Associated Virus)
  • IHHNV (Infectious Hypodermal and Hematopoietic Virus)
  • HPV (Hepatopancreatic Parvovirus)
  • MBV (Monodon Baculovirus)
  • IMNV (Infectious Myonecrosis Virus)
  • NHP-B (Necrotising Hepatopancreatitis Bacteria)
  • MoV (Mourilyan Virus)
  • Early Mortality Syndrome (EMS)

End User:

  • Fisheries
  • Aquaculture Laboratories
  • Marine Laboratories
  • Education and Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Recent Product Approvals
  • 4.3. Regulatory Landscape
  • 4.4. Reimbursement Scenario
  • 4.5. Supply Chain Analysis
  • 4.6. Porter's Analysis
  • 4.7. PESTLE Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Animal Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growing Healthcare Expenditure
    • 5.2.2. Historic and Current Revenue of Key Players
    • 5.2.3. Increasing Adoption of Diagnostic Tools
    • 5.2.4. Rising Incidences of Infectious Diseases
    • 5.2.5. Introduction of New and Advance Reagent Kits and Devices
    • 5.2.6. High Cost of Diagnostic kits
    • 5.2.7. Increasing Research and Development Activities to Develop Diagnostic Tools
    • 5.2.8. Strategic Collaboration Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Reagent Kits
    • 6.1.2. By Disease
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Reagent Kits

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Reagent Kits, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Reagent Kits, 2024-2033
    • 8.3.1. Rapid Testing Kits
    • 8.3.2. Assay Based Kits
  • 8.4. Market Attractiveness Analysis by Reagent Kits

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
    • 9.3.1. WSSV (White Spot Syndrome Virus)
    • 9.3.2. TSV (Taura Syndrome Virus)
    • 9.3.3. YHV/GAV (Yellow Head/Gill Associated Virus)
    • 9.3.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
    • 9.3.5. HPV (Hepatopancreatic Parvovirus)
    • 9.3.6. MBV (Monodon Baculovirus)
    • 9.3.7. IMNV (Infectious Myonecrosis Virus)
    • 9.3.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
    • 9.3.9. MoV (Mourilyan Virus)
    • 9.3.10. Early Mortality Syndrome (EMS)
  • 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
    • 10.3.1. Fisheries
    • 10.3.2. Aquaculture Laboratories
    • 10.3.3. Marine Laboratories
    • 10.3.4. Education and Research Institutes
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East & Africa
  • 11.4. Market Attractiveness Analysis by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Reagent Kits
    • 12.3.3. By Disease
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Reagent Kits
    • 12.4.3. By Disease
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Reagent Kits
        • 12.8.1.2.2. By Disease
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Reagent Kits
        • 12.8.2.2.2. By Disease
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Reagent Kits
    • 13.3.3. By Disease
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Reagent Kits
    • 13.4.3. By Disease
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Reagent Kits
        • 13.8.1.2.2. By Disease
        • 13.8.1.2.3. By End User
    • 13.8.2. Brazil Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Reagent Kits
        • 13.8.2.2.2. By Disease
        • 13.8.2.2.3. By End User
    • 13.8.3. Argentina Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Reagent Kits
        • 13.8.3.2.2. By Disease
        • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Reagent Kits
    • 14.3.3. By Disease
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Reagent Kits
    • 14.4.3. By Disease
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Reagent Kits
        • 14.8.1.2.2. By Disease
        • 14.8.1.2.3. By End User
    • 14.8.2. Italy Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Reagent Kits
        • 14.8.2.2.2. By Disease
        • 14.8.2.2.3. By End User
    • 14.8.3. France Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Reagent Kits
        • 14.8.3.2.2. By Disease
        • 14.8.3.2.3. By End User
    • 14.8.4. U.K. Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Reagent Kits
        • 14.8.4.2.2. By Disease
        • 14.8.4.2.3. By End User
    • 14.8.5. Spain Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Reagent Kits
        • 14.8.5.2.2. By Disease
        • 14.8.5.2.3. By End User
    • 14.8.6. BENELUX Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Reagent Kits
        • 14.8.6.2.2. By Disease
        • 14.8.6.2.3. By End User
    • 14.8.7. Russia Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Reagent Kits
        • 14.8.7.2.2. By Disease
        • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Reagent Kits
    • 15.3.3. By Disease
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Reagent Kits
    • 15.4.3. By Disease
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Reagent Kits
        • 15.8.1.2.2. By Disease
        • 15.8.1.2.3. By End User
    • 15.8.2. Japan Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Reagent Kits
        • 15.8.2.2.2. By Disease
        • 15.8.2.2.3. By End User
    • 15.8.3. South Korea Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Reagent Kits
        • 15.8.3.2.2. By Disease
        • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Reagent Kits
    • 16.3.3. By Disease
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Reagent Kits
    • 16.4.2. By Disease
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Reagent Kits
        • 16.8.1.2.2. By Disease
        • 16.8.1.2.3. By End User
    • 16.8.2. Indonesia Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Reagent Kits
        • 16.8.2.2.2. By Disease
        • 16.8.2.2.3. By End User
    • 16.8.3. Malaysia Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Reagent Kits
        • 16.8.3.2.2. By Disease
        • 16.8.3.2.3. By End User
    • 16.8.4. Thailand Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Reagent Kits
        • 16.8.4.2.2. By Disease
        • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Reagent Kits
    • 17.3.3. By Disease
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Reagent Kits
    • 17.4.2. By Disease
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Reagent Kits
        • 17.8.1.2.2. By Disease
        • 17.8.1.2.3. By End User
    • 17.8.2. New Zealand Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Reagent Kits
        • 17.8.2.2.2. By Disease
        • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. North Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Reagent Kits
    • 18.3.3. By Disease
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Reagent Kits
    • 18.4.3. By Disease
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Reagent Kits
        • 18.8.1.2.2. By Disease
        • 18.8.1.2.3. By End User
    • 18.8.2. Turkiye Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Reagent Kits
        • 18.8.2.2.2. By Disease
        • 18.8.2.2.3. By End User
    • 18.8.3. South Africa Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Reagent Kits
        • 18.8.3.2.2. By Disease
        • 18.8.3.2.3. By End User
    • 18.8.4. North Africa Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Reagent Kits
        • 18.8.4.2.2. By Disease
        • 18.8.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Branding and Promotional Strategies
  • 20.3. Key Development Analysis
  • 20.4. Competition Deep Dive
    • 20.4.1. HiMedia Laboratories
      • 20.4.1.1. Overview
      • 20.4.1.2. Product Portfolio
      • 20.4.1.3. Sales Footprint
      • 20.4.1.4. Key Financials
      • 20.4.1.5. SWOT Analysis
      • 20.4.1.6. Strategy Overview
        • 20.4.1.6.1. Marketing Strategy
        • 20.4.1.6.2. Product Strategy
        • 20.4.1.6.3. Channel Strategy
    • 20.4.2. HiMedia Laboratories
      • 20.4.2.1. Overview
      • 20.4.2.2. Product Portfolio
      • 20.4.2.3. Sales Footprint
      • 20.4.2.4. Key Financials
      • 20.4.2.5. SWOT Analysis
      • 20.4.2.6. Strategy Overview
        • 20.4.2.6.1. Marketing Strategy
        • 20.4.2.6.2. Product Strategy
        • 20.4.2.6.3. Channel Strategy
    • 20.4.3. Speedy Assay Sdn Bhd
      • 20.4.3.1. Overview
      • 20.4.3.2. Product Portfolio
      • 20.4.3.3. Sales Footprint
      • 20.4.3.4. Key Financials
      • 20.4.3.5. SWOT Analysis
      • 20.4.3.6. Strategy Overview
        • 20.4.3.6.1. Marketing Strategy
        • 20.4.3.6.2. Product Strategy
        • 20.4.3.6.3. Channel Strategy
    • 20.4.4. REAGEN LLC
      • 20.4.4.1. Overview
      • 20.4.4.2. Product Portfolio
      • 20.4.4.3. Sales Footprint
      • 20.4.4.4. Key Financials
      • 20.4.4.5. SWOT Analysis
      • 20.4.4.6. Strategy Overview
        • 20.4.4.6.1. Marketing Strategy
        • 20.4.4.6.2. Product Strategy
        • 20.4.4.6.3. Channel Strategy
    • 20.4.5. FUJIKURA KASEI CO., LTD.
      • 20.4.5.1. Overview
      • 20.4.5.2. Product Portfolio
      • 20.4.5.3. Sales Footprint
      • 20.4.5.4. Key Financials
      • 20.4.5.5. SWOT Analysis
      • 20.4.5.6. Strategy Overview
        • 20.4.5.6.1. Marketing Strategy
        • 20.4.5.6.2. Product Strategy
        • 20.4.5.6.3. Channel Strategy
    • 20.4.6. GeneReach Biotechnology Corp.
      • 20.4.6.1. Overview
      • 20.4.6.2. Product Portfolio
      • 20.4.6.3. Sales Footprint
      • 20.4.6.4. Key Financials
      • 20.4.6.5. SWOT Analysis
      • 20.4.6.6. Strategy Overview
        • 20.4.6.6.1. Marketing Strategy
        • 20.4.6.6.2. Product Strategy
        • 20.4.6.6.3. Channel Strategy
    • 20.4.7. Thermo Fisher Scientific
      • 20.4.7.1. Overview
      • 20.4.7.2. Product Portfolio
      • 20.4.7.3. Sales Footprint
      • 20.4.7.4. Key Financials
      • 20.4.7.5. SWOT Analysis
      • 20.4.7.6. Strategy Overview
        • 20.4.7.6.1. Marketing Strategy
        • 20.4.7.6.2. Product Strategy
        • 20.4.7.6.3. Channel Strategy
    • 20.4.8. Lab - Ind Resource Sdn Bhd.
      • 20.4.8.1. Overview
      • 20.4.8.2. Product Portfolio
      • 20.4.8.3. Sales Footprint
      • 20.4.8.4. Key Financials
      • 20.4.8.5. SWOT Analysis
      • 20.4.8.6. Strategy Overview
        • 20.4.8.6.1. Marketing Strategy
        • 20.4.8.6.2. Product Strategy
        • 20.4.8.6.3. Channel Strategy
    • 20.4.9. SUREBIO
      • 20.4.9.1. Overview
      • 20.4.9.2. Product Portfolio
      • 20.4.9.3. Sales Footprint
      • 20.4.9.4. Key Financials
      • 20.4.9.5. SWOT Analysis
      • 20.4.9.6. Strategy Overview
        • 20.4.9.6.1. Marketing Strategy
        • 20.4.9.6.2. Product Strategy
        • 20.4.9.6.3. Channel Strategy
    • 20.4.10. Auro Biotechnologies Pvt. Ltd.
      • 20.4.10.1. Overview
      • 20.4.10.2. Product Portfolio
      • 20.4.10.3. Sales Footprint
      • 20.4.10.4. Key Financials
      • 20.4.10.5. SWOT Analysis
      • 20.4.10.6. Strategy Overview
        • 20.4.10.6.1. Marketing Strategy
        • 20.4.10.6.2. Product Strategy
        • 20.4.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology